AI Digital Twins Are Helping People Manage Diabetes and Obesity
As patients and employers look for alternatives to pricey GLP-1 drugs, Silicon Valley startup Twin Health is using AI and wearable sensors to help people make healthier choices.
RFK Jr. Says Americans Need More Protein. His Grok-Powered Food Website Disagrees
The site Realfood.gov uses Elon Musk’s Grok chatbot to dispense nutrition information—some of which contradicts the government’s new guidelines.
Measles Is Causing Brain Swelling in Children in South Carolina
In the ongoing measles outbreak in South Carolina that has infected more than 800 people, some children have developed a rare but serious complication called encephalitis.
HHS Is Making an AI Tool to Create Hypotheses About Vaccine Injury Claims
Experts worry Robert F. Kennedy Jr.’s Health Department will use an internal AI tool to analyze vaccine injury claims in a way that furthers his anti-vaccine agenda.
This Chinese Startup Wants to Build a New Brain-Computer Interface—No Implant Required
Gestala is the latest company to emerge from China’s burgeoning brain-computer interface industry. It plans to access the brain with noninvasive ultrasound technology.
The US Is In For Another Bad Year of Measles Cases
A growing measles outbreak in South Carolina has infected more than 600 people since October, with hundreds more being potentially exposed.
He Went to Prison for Gene-Editing Babies. Now He’s Planning to Do It Again
Chinese scientist He Jiankui wants to end Alzheimer’s and thinks Silicon Valley is conducting a “Nazi eugenic experiment.”
OpenAI Invests in Sam Altman’s New Brain-Tech Startup Merge Labs
Merge Labs has emerged from stealth with $252 million in funding from OpenAI and others. It aims to use ultrasound to read from and write to the brain.
Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments
Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases.
FDA Approves Pill Version of Wegovy
Novo Nordisk’s semaglutide will soon be available in a daily pill Americans can take for weight loss.